# oxaliplatin

NDC: 25021-233
Generic name: oxaliplatin
Labeler / Manufacturer: Sagent Pharmaceuticals
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: INJECTION, SOLUTION
Routes: INTRAVENOUS
Marketing started: 20140915

FDA application: ANDA203869

## Active ingredients

- OXALIPLATIN: 5 mg/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"25021-233"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=25021-233
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=29a5d098-bfa7-4a65-bb4f-5daa1fef1c2f